Evidence map›Paper›PMID 32503597›Full record

ArticleJournal of orthopaedic surgery and research2020

Bioinformatic analysis and experimental identification of blood biomarkers for chronic nonunion.

Jingwei Wu, Limin Liu, Huaijian Hu, Zhihua Gao, Shibao Lu

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Bone Regenerate Evaluation Methods.Revista brasileira de ortopedia · 2024
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jingwei WuDepartment of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China.
Limin LiuDepartment of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China. xwllm2019@sina.com.ORCID http://orcid.org/0000-0001-9167-9079
Huaijian HuDepartment of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China.
Zhihua GaoDepartment of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China.
Shibao LuDepartment of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People's Republic of China. xwlushibao@aliyun.com.
Capital Medical University · CN

Funding

Xuanwu Hospital Funding Project XWJK-2019033
6 · The paper itself

Abstract

backgroundIncomplete fracture healing may lead to chronic nonunion; thus, determining fracture healing is the primary issue in the clinical treatment. However, there are no validated early diagnostic biomarkers for assessing chronic nonunion. In this study, bioinformatics analysis combined with an experimental verification strategy was used to identify blood biomarkers for chronic nonunion.

methodsFirst, differentially expressed genes in chronic nonunion were identified by microarray data analysis. Second, Dipsaci Radix (DR), a traditional Chinese medicine for fracture treatment, was used to screen the drug target genes. Third, the drug-disease network was determined, and biomarker genes were obtained. Finally, the potential blood biomarkers were verified by ELISA and qPCR methods.

resultsFifty-five patients with open long bone fractures (39 healed and 16 nonunion) were enrolled in this study, and urgent surgical debridement and the severity of soft tissue injury had a significant effect on the prognosis of fracture. After the systems pharmacology analysis, six genes, including QPCT, CA1, LDHB, MMP9, UGCG, and HCAR2, were chosen for experimental validation. We found that all six genes in peripheral blood mononuclear cells (PBMCs) and serum were differentially expressed after injury, and five genes (QPCT, CA1, MMP9, UGCG, and HCAR2) were significantly lower in nonunion patients. Further, CA1, MMP9, and QPCT were markedly increased after DR treatment.

conclusionCA1, MMP9, and QPCT are biomarkers of nonunion patients and DR treatment targets. However, HCAR2 and UGCG are biomarkers of nonunion patients but not DR treatment targets. Therefore, our findings may provide valuable information for nonunion diagnosis and DR treatment.

trial registrationISRCTN, ISRCTN13271153. Registered 05 April 2020-Retrospectively registered.

Indexed as

AdultAminoacyltransferasesAntibodiesBiomarkersChronic DiseaseComputational BiologyFemaleFracture HealingFractures, UnunitedHumansLactate DehydrogenasesMaleMatrix Metalloproteinase 9Middle AgedMonosaccharide Transport ProteinsReceptors, G-Protein-CoupledAminoacyltransferasesAntibodiesBiomarkersCa1 antibodyD-lactate dehydrogenaseglutaminyl-peptide cyclotransferaseHCAR2 protein, humanLactate DehydrogenasesMatrix Metalloproteinase 9MMP9 protein, humanMonosaccharide Transport ProteinsReceptors, G-Protein-CoupledUDP-Galactose TranslocatorsBiomarkerDipsaci Radix (DR)FractureNonunion

Identifiers

PMID32503597
PMCPMC7275361
OpenAlexW3033154305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.